NELL-1–Associated Membranous Nephropathy Induced by Long-Term Penicillamine Treatment in a Patient With Wilson’s Disease
Ahmet Burak Dirim, Ozge Hurdogan, Ozgur Akin Oto, Ayse Serra Artan, Vafa Suleymanova, Kadir Demir, Aslı Cifcibasi Ormeci, Yasemin Ozluk, Savas Ozturk, Isin Kilicaslan, Halil Yazici · 2024
Read NELL-1–Associated Membranous Nephropathy Induced by Long-Term Penicillamine Treatment in a Patient With Wilson’s Disease by Ahmet Burak Dirim, Ozge Hurdogan, Ozgur Akin Oto, Ayse Serra Artan, Vafa Suleymanova, Kadir Demir, Aslı Cifcibasi Ormeci, Yasemin Ozluk, Savas Ozturk, Isin Kilicaslan, Halil Yazici (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11843114.txt.
Description
Ahmet Dirim and ten co-authors report a kidney illness sparked by a copper drug, in a 2024 letter. A 27-year-old man with Wilson disease, where copper builds up in the body, had taken a copper-clearing drug for seven years. He arrived with a kidney syndrome that leaks protein into urine. A biopsy showed a membrane pattern in the kidney filters that fits an immune attack.
Doctors stopped the drug and swapped in a gentler copper clearer, then added immune-calming drugs when leaks persisted. Nearly two years on, he reached full remission. Staining the stored biopsy for a named marker came back positive, tying his case to a known marker-linked form of the disease. A cousin drug had caused the same pattern before. The authors urge kidney checks for patients on long runs of this drug class.
Catalog record
| CREATOR | Ahmet Burak Dirim, Ozge Hurdogan, Ozgur Akin Oto, Ayse Serra Artan, Vafa Suleymanova, Kadir Demir, Aslı Cifcibasi Ormeci, Yasemin Ozluk, Savas Ozturk, Isin Kilicaslan, Halil Yazici |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 4 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |